Research Review of Curcumin’s Immune Benefits by Sabinsa Founder Dr. Muhammed Majeed Published
- Details
- Press Release
- 1037

In these uncertain days of the highly contagious coronavirus, the absence of pharmaceutical intervention in the form of drugs or vaccines has pushed scientists to look for clues among safe herbal extract ingredients. A recent peer-reviewed scientific article co-authored by the founder and chairman of Sabinsa, Dr. Muhammed Majeed, along with a galaxy of other scientists, reviews the possible role of curcumin in COVID-19 scenarios with supporting evidence from existing literature.
Sabinsa's pTeroWhite® Subject of Two New Published Studies Reporting Anti-Aging, Skin Brightening, and SPF Benefits
- Details
- Press Release
- 842

Two new studies have recently been published on the topical benefits of Sabinsa’s pTeroWhite® natural pterostilbene isolated and purified from Pterocarpus marsupium heartwood and formulated as a cream. The studies further the body of science into pTeroWhite’s value as a cosmeceutical ingredient for anti-aging, skin brightening, and as a natural SPF agent.
Sami-Sabinsa Group Celebrates Three Prestigious Awards From ASSOCHAM
- Details
- Press Release
- 914

Dr. Majeed, Sami-Sabinsa Group’s Founder & Chairman, received the ‘Legend of Natural Cosmeceuticals’ award from Mr. Sandeep Marwah Chancellor, AAFT University of Media & Art and Her Excellency Ms. Jennifer Graham, Spouse of His Excellency Mr. Nadir Patel, Canadian High Commission of India.
Sami-Sabinsa Group, a pioneer and global leader in health science, was honored with three awards by the Associated Chambers of Commerce and Industry of India (ASSOCHAM) at the 3rd edition of their Beauty, Wellness and Personal Care Awards held in New Delhi on February 28, 2020.
Sabinsa to Feature Dispersible Curcumin and Functional GRAS Ingredients at Expo West
- Details
- Press Release
- 1148

Shaheen Majeed, President Worldwide, to speak about sustainability
Sabinsa will demonstrate a delicious next-generation solution for its #1 clinically studied brand of curcumin, Curcumin C3 Complex® as well as highlighting a number of GRAS-affirmed, science-based ingredients from the company’s substantial portfolio at Natural Products Expo West from March 5 – 7, 2020 at the Anaheim Convention Center, Anaheim, CA.
Sabinsa’s Parent Company Sami Labs Breaks Ground on $30 Million USD State-of-the-Art Production Facility in India
- Details
- Press Release
- 1008

Sami-Sabinsa Group hosted a ground-breaking ceremony, on January 20, 2020, for a new Active Pharmaceutical Ingredients (API) manufacturing unit at Pharma SEZ Industrial Area, Hassan, Karnataka. The latest facility, with a planned investment of $30 Million USD, is part of the group’s strategy to expand existing ingredient growth, and focus on innovative new products. This will be the company’s eighth manufacturing facility.
Sabinsa Named a Top New Jersey Company for Its Dynamic Growth
- Details
- Press Release
- 1007

The award was accepted by Ms. Asha Ramesh, Sabinsa USA’s CEO at an awards ceremony on November 14, 2019.
When the fastest growing 50 companies in New Jersey were announced by NJBIZ, a leading business journal in the state, Sabinsa was pleased to be identified as the 15th of the Fast 50.
Sabinsa Issued New U.S. Patent for LactoSpore® Based upon Published Research Confirming Ability to Reverse Depression Symptoms in Patients Suffering from IBS
- Details
- Press Release
- 993

Sabinsa has been granted U.S. patent US10166261 for a method of managing dementia and dementia-related sleep disorders presented as symptoms of major depressive disorder (MDD) in humans associated with Irritable Bowel Syndrome (IBS) by administering Bacillus coagulans MTCC 5856 (LactoSpore®) at a dose of 2 billion colony forming units per day. The patent also claims LactoSpore’s ability to reduce serum myeloperoxidase, an essential biochemical marker of MDD.
Sabinsa’s Pterostilbene in Silbinol® Subject of Published Study
- Details
- Press Release
- 1027

Reduction of TMAO Formation Found, Novel Findings for Heart Health
A new study collaboratively published by Sabinsa researchers and academic scientists from Taiwan and China, demonstrates that Sabinsa’s sustainably-sourced pterostilbene attenuates Trimethylamine-N-oxide (TMAO) formation and decreases vascular inflammation, confirming cardioprotective properties. The animal study findings were published online in the article Prevention of Vascular Inflammation by Pterostilbene via Trimethylamine-N-Oxide Reduction and Mechanism of Microbiota Regulation in Molecular Nutrition and Food Research (Volume 63, Issue 20).
Sabinsa’s Parent Dubbed Most Trusted Nutraceutical Company
- Details
- Press Release
- 1011

Award Presented During the Economic Times Business Leaders 2019 Award Ceremony
Sabinsa’s parent company Sami Labs Limited received The Economic Times’ Business Leaders 2019 Award for Most Trusted Nutraceutical Company in a ceremony held in Mumbai, India last month. The Economic Times, is the leading financial daily in India and among the world’s top three daily newspapers.
Government of Karnataka State, India Recognizes the Sami- Sabinsa Group with Three Awards for Export Excellence
- Details
- Press Release
- 1058

The Sami-Sabinsa Group’s export success was recently recognized by the Visveshwaraiah Trade Promotion Centre (VTPC), under the auspices of the Industries Department, Government of Karnataka, India. Sabinsa’s parent company Sami Labs Limited received three Export Excellence Awards for the financial year 2016-17.
© 2021 Sabinsa. All Rights Reserved | Powered by Edkal Technologies | Disclaimer